| 000 | 01091 a2200277 4500 | ||
|---|---|---|---|
| 005 | 20250516155710.0 | ||
| 264 | 0 | _c20140228 | |
| 008 | 201402s 0 0 jpn d | ||
| 022 | _a1349-7413 | ||
| 024 | 7 |
_a10.2177/jsci.36.162 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aTakami, Masamichi | |
| 245 | 0 | 0 |
_a[Development and pharmacological effects of anti-RANKL monoclonal antibody drug denosumab]. _h[electronic resource] |
| 260 |
_bNihon Rinsho Men'eki Gakkai kaishi = Japanese journal of clinical immunology _c2013 |
||
| 300 |
_a162-9 p. _bdigital |
||
| 500 | _aPublication Type: English Abstract; Journal Article; Review | ||
| 650 | 0 | 4 | _aAnimals |
| 650 | 0 | 4 |
_aAntibodies, Monoclonal, Humanized _xchemistry |
| 650 | 0 | 4 |
_aBone Diseases _xdrug therapy |
| 650 | 0 | 4 | _aDenosumab |
| 650 | 0 | 4 | _aDrug Design |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 |
_aRANK Ligand _xchemistry |
| 773 | 0 |
_tNihon Rinsho Men'eki Gakkai kaishi = Japanese journal of clinical immunology _gvol. 36 _gno. 3 _gp. 162-9 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.2177/jsci.36.162 _zAvailable from publisher's website |
| 999 |
_c22877600 _d22877600 |
||